Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Inverness Medical Techno. (AMEX:IMA)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
51 Sawyer Road, Suite 200
Waltham, MA 02453
Phone: (781) 647-3900
Fax: (781) 647-3939
Email: invest@invernessmedical.com
Employees (last reported count): 871
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Scientific & Technical Instr.
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 19%
·Over the last 6 months:
 · 14 insider sells; 136.0K shares
  (2.1% of insider shares)
·Institutional: 41% (50% of float)
(147 institutions)
·Net Inst. Selling: 899.0K shares (+7.33%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Inverness Medical Technology, Inc., formerly Selfcare, Inc., develops, manufactures and markets products focused primarily on diabetes self-management. The Company's principal products are advanced electrochemical blood glucose-monitoring systems that are used by people with diabetes to determine their blood glucose levels. Such systems utilize the Company's proprietary biosensor test strips, which quickly draw blood into the strip, require a small sample and provide users with the option of sampling from the forearm, thus avoiding the need for finger sticking. The Company also sells products for the women's health market and, to a lesser extent, the infectious disease market. Products for the women's health market include home pregnancy detection tests, ovulation prediction tests and a line of nutritional supplements. Products for the infectious disease market include tests used for the detection of certain diseases and agents, such as HIV-1 and HIV-2, hepatitis and chlamydia.
More from Market Guide: Expanded Business Description

Financial Summary
Inverness Medical Technology, Inc. develops, manufactures and markets self-test and self-care products for the diabetes, women's health and infectious disease markets. For the six months ended 6/30/01, net revenues increased 45% to $111.7 million. Net loss before extraordinary item and applicable to Common totaled $52.5 million vs. an income of $4.6 million. Revenues reflect increased sales of the blood glucose monitoring system. Net loss reflects the charge for in-process R&D.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Ron Zwanziger, 47
Chairman, Pres and CEO
$350K$6.8M
John Wilkens, 53
Managing Director, Iverness Medical Limited
--  --  
Kenneth Legg, Ph.D., 58
Exec. VP, Sec.
203K--  
Duane James, 41
VP-Fin., Treasurer
--  --  
John Yonkin, 41
VP of Sales and Marketing,and Gen. Mang..
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:IMAAs of 31-Aug-2001
Price and Volume
52-Week Low
on 8-Sep-2000
$16.375
Recent Price$37.60 
52-Week High
on 28-Dec-2000
$41.00 
Beta0.26 
Daily Volume (3-month avg)202.4K
Daily Volume (10-day avg)136.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+97.9%
52-Week Change
relative to S&P500
+165.5%
Share-Related Items
Market Capitalization$1.22B
Shares Outstanding32.4M
Float26.2M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$4.82 
Earnings (ttm)-$1.47 
Earnings (mrq)$0.01 
Sales (ttm)$6.44 
Cash (mrq)$0.96 
Valuation Ratios
Price/Book (mrq)7.81 
Price/EarningsN/A 
Price/Sales (ttm)5.84 
Income Statements
Sales (ttm)$205.1M
EBITDA (ttm)-$31.4M
Income available to common (ttm)-$44.4M
Profitability
Profit Margin (ttm)-21.7%
Operating Margin (ttm)-19.2%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-24.68%
Return on Equity (ttm)-45.28%
Financial Strength
Current Ratio (mrq)1.75 
Debt/Equity (mrq)0.14 
Total Cash (mrq)$31.2M
Short Interest
As of 8-Aug-2001
Shares Short550.0K
Percent of Float2.1%
Shares Short
(Prior Month)
0 
Short Ratio3.67 
Daily Volume150.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.